New York Public Health Law Title 1 - PREFERRED DRUG AND CLINICAL DRUG REVIEW PROGRAMS

• 270 - Definitions.
  As used in this article, unless the context clearly requires otherwise: 1. "Administrator" means an entity with which the commissioner contracts for the purpose of...
• 272 - Preferred Drug Program.
  1. There is hereby established a preferred drug program to promote access to the most effective prescription drugs while reducing the cost of prescription drugs...
• 273 - Preferred Drug Program Prior Authorization.
  1. For the purposes of this article, a prescription drug shall be considered to be not on the preferred drug list if it is a...
• 274 - Clinical Drug Review Program.
  1. In addition to the preferred drug program established by this article, the commissioner may establish a clinical drug review program. The commissioner may, from...
• 275 - Applicability of Prior Authorization to Epic.
  The panel shall, no later than April first, two thousand eight, proceed to make prior authorization under the preferred drug program and the clinical review...
• 276 - Education and Outreach.
  The department or the panel may conduct education and outreach programs for consumers and health care providers relating to the safe, therapeutic and cost-effective use...
• 277 - Review and Reports.
  1. The commissioner, in consultation with the drug utilization review board, shall undertake periodic reviews, at least annually, of the preferred drug program which shall...

Last modified: February 3, 2019